It's Official: Apple Wins the Race to $1 Trillion

This momentous occasion has been a long time coming, but Apple (NASDAQ:AAPL) officially crossed the threshold ($207.04 per share) that puts its total market cap into 13-digit territory, becoming the first U.S. company valued at $1 trillion. Technically, China's PetroChina was the first company in the world to briefly�hit a $1 trillion market cap back in 2007 before losing roughly 80% of its value since.

Amazon.com had been closing the gap in recent years, with the e-commerce giant's stock posting strong gains as it continues to grow and expand into more and more markets, but Apple's strong fiscal third-quarter earnings release earlier this week helped propel the Mac maker's shares higher, as investors cheered strong guidance and accelerating revenue growth.

AAPL Market Cap data by YCharts.

Cheap at $1 trillion

While $1 trillion in market valuation is an awful lot of money, it's worth noting that Apple remains incredibly cheap relative to its earnings power. The Mac maker has long traded at a discount to the S&P 500, and still does. Here's how Apple's valuation metrics compare to the broader market as well as some large tech peers.

Company or Index

P/E Ratio

P/S Ratio

S&P 500	24.3	2.2
Apple	17.5	3.7
Amazon.com	249.7	3.2
Alphabet	33.1	6.9
Facebook	23.7	10.3
Microsoft	28.1	6.5

Data sources: Multpl.com and Reuters.

Relative to its earnings power, Apple is the cheapest among its peers by a meaningful margin.

CEO Tim Cook holding the billionth iPhone. Image source: Apple.

How buybacks affect Apple's market cap

Incredibly, Apple has repurchased a mind-boggling $219.6 billion worth of its stock since kicking off its capital return program nearly six years ago. These repurchase activities have significantly accelerated in recent quarters following tax reform.

Data source: SEC filings. Chart by author. Calendar quarters shown.

These buybacks have been conducted at various share prices over the years, but the company has now retired over (split-adjusted) 1.7 billion shares outstanding relative to its peak of shares outstanding in 2013.

AAPL Shares Outstanding data by YCharts.

At current prices, those 1.7 billion shares would be worth $360 billion. Of course, it's not that simple. Apple's buybacks are so massive that the repurchases are highly accretive to earnings, allowing net income to be distributed across fewer shares and allowing EPS growth to outpace net income growth. That helps boost Apple's stock price.

So there are opposing forces at play regarding how buybacks affect Apple's market cap: Buying back shares reduces its market cap by decreasing the number of shares outstanding, but the resulting earnings accretion helps drive prices higher.

While impressive, the reality is that a $1 trillion market cap is still a somewhat arbitrary milestone that has little bearing on the company's underlying fundamentals. Apple is the most profitable company on Earth, and long-term shareholders are getting increasingly bigger cuts of those profits.

Disney wins: Comcast drops its bid for 21st Century Fox

Disney has won the war for 21st Century Fox.

Comcast announced Thursday that it will drop its pursuit of the 21st Century Fox assets that it was fighting over with Disney.

Comcast had bid $65 billion for Fox's movie studio, which is responsible for franchises like "Avatar" and "X-Men," along with Fox's regional sports networks and cable channels like FX and National Geographic. Disney's most recent bid was $71 billion.

The battle with Disney isn't completely over: Comcast said Thursday it will continue to pursue its bid for British broadcaster Sky, which Disney is also trying to buy through Fox. Comcast has offered $34 billion for that company.

A Comcast takeover of Sky would deprive Fox, and thus Disney, of a major direct-to-consumer platform in Europe that Iger has described as a "crown jewel" of the Fox assets.

Over the course of the bidding war, 21st Century Fox's value surged 36% as Disney, then Comcast, then Disney again bid for rights to most of Rupert Murdoch's media empire.

The Murdochs will hold onto their broadcast, news and national sports programming, including Fox News, Fox Business and Fox Sports. The new company, known as "New Fox," will be headed by Lachlan Murdoch.

"I'd like to congratulate Bob Iger and the team at Disney and commend the Murdoch family and Fox for creating such a desirable and respected company," Comcast chief Brian Roberts said in a statement.

The bidding war between Iger and Roberts had become one of the most closely followed stories among Hollywood executives, given the sheer scale of the acquisition and the two men's well-known dislike for one another.

By winning the war for Fox, Disney will now have arguably the most formidable content portfolio in all of Hollywood, adding to an already impressive stable that includes Marvel, Pixar and LucasFilm.

But Sky is the other piece of the puzzle: One of Disney's top priorities is building direct-to-consumer relationships globally, so that it can compete with the likes of Netflix and Amazon. Sky has a direct-to-consumer relationship with 23 million paying subscribers across five European countries, making it a key part of the overall Fox acquisition.

Should Sky go to Comcast, Iger would effectively cede the direct-to-consumer market in Europe to Roberts, who would then oversee the biggest pay-TV provider in the world.

Disney won the US Justice Department's approval for its acquisition of Fox assets last month. It agreed to spin off Fox's sports networks to get the government's blessing.

In an unrelated but equally consequential decision, the Justice Department last week appealed a court's approval of AT&T's purchase of Time Warner, the parent company of CNN.

That effectively drove a stake through Comcast's chances of buying Fox: Comcast's deal looks a lot more like AT&T's Time Warner purchase than Disney's Fox bid.

Rivernorth Opportunities Fund Inc (RIV) Declares $0.21 Monthly Dividend

Rivernorth Opportunities Fund Inc (NYSE:RIV) announced a monthly dividend on Thursday, July 19th, Wall Street Journal reports. Investors of record on Wednesday, October 17th will be given a dividend of 0.21 per share on Wednesday, October 31st. This represents a $2.52 dividend on an annualized basis and a dividend yield of 12.97%. The ex-dividend date of this dividend is Tuesday, October 16th.

Shares of RIV traded down $1.26 on Thursday, reaching $19.43. The stock had a trading volume of 356,688 shares, compared to its average volume of 46,741. Rivernorth Opportunities Fund has a twelve month low of $18.97 and a twelve month high of $21.63.

Get Rivernorth Opportunities Fund alerts:

In related news, insider Rivernorth Capital Management, sold 10,445 shares of the company’s stock in a transaction that occurred on Monday, June 4th. The stock was sold at an average price of $21.37, for a total value of $223,209.65. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In the last 90 days, insiders sold 38,833 shares of company stock worth $829,917.

About Rivernorth Opportunities Fund

Rivernorth Opportunities Fund, Inc (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is total return consisting of capital appreciation and current income. The Fund seeks to achieve its investment objective by pursuing a tactical asset allocation strategy and opportunistically investing under normal circumstances in closed-end funds and exchange-traded funds (ETFs, and collectively, Underlying Funds).

See Also: Short Selling Stocks and Day Traders

Hot Oil Stocks To Watch For 2019

tags:WPZ,ECA,MRO,RRC, Related LGCY Marathon Oil Shares, Other Peers Fall After Capex Cut JPMorgan: More MLP Distribution Cuts Coming In 2016 Related GOOGL Mid-Day Market Update: Microsoft Drops On Earnings Miss; NGL Energy Partners Shares Surge Alphabet Crushed After Q1 Report Big Tech Stocks Down Hard, But Small Caps Up; Hawaiian Air Hits "Eject" Button (Investor's Business Daily)

Toward the end of trading Friday, the Dow traded up 0.10 percent to 18,001.14 while the NASDAQ declined 0.90 percent to 4,901.21. The S&P also fell, dropping 0.01 percent to 2,091.31.

Leading and Lagging Sectors

On Friday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from NGL Energy Partners LP (NYSE: NGL) and Legacy Reserves LP (NASDAQ: LGCY).

In trading on Friday, technology shares fell by 1.73 percent. Meanwhile, top losers in the sector included Microsoft Corporation (NASDAQ: MSFT), down 7 percent, and Alphabet Inc (NASDAQ: GOOGL), down 5 percent.

Hot Oil Stocks To Watch For 2019: Williams Partners L.P.(WPZ)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Williams Pipeline Partners (WPZ)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'. CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting. Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss. Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session. Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results. World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading. Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal. Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday. Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday. Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday. Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

   

• [By Shane Hupp]

  Williams Pipeline Partners LP (NYSE:WPZ) – US Capital Advisors decreased their Q3 2018 earnings per share (EPS) estimates for shares of Williams Pipeline Partners in a research note issued to investors on Monday, May 14th. US Capital Advisors analyst B. Followill now forecasts that the pipeline company will post earnings per share of $0.39 for the quarter, down from their previous forecast of $0.41. US Capital Advisors also issued estimates for Williams Pipeline Partners’ Q4 2018 earnings at $0.45 EPS and FY2019 earnings at $1.87 EPS.

• [By Matthew DiLallo]

  Natural gas pipeline giant Williams Companies (NYSE:WMB) announced today that it agreed to acquire the rest of its master limited partnership (MLP) Williams Partners (NYSE:WPZ) that it didn't already own in a $10.5 billion deal. Not to be outdone, Canadian energy infrastructure giant Enbridge (NYSE:ENB) made an offer to acquire its namesake MLP Enbridge Energy Partners (NYSE:EEP), along with the rest of its publicly traded entities, including Spectra Energy Partners (NYSE:SEP). These transactions have big implications not only for investors in these entities but for those who own other pipeline companies, too.

Hot Oil Stocks To Watch For 2019: Encana Corporation(ECA)

Advisors' Opinion:

• [By Max Byerly]

  Electra (CURRENCY:ECA) traded 8% higher against the U.S. dollar during the 1-day period ending at 22:00 PM ET on June 20th. In the last week, Electra has traded 12.6% higher against the U.S. dollar. Electra has a market capitalization of $34.87 million and $128,874.00 worth of Electra was traded on exchanges in the last 24 hours. One Electra coin can now be purchased for $0.0014 or 0.00000020 BTC on exchanges including Fatbtc, Novaexchange, CoinFalcon and CryptoBridge.

• [By Shane Hupp]

  Electra (CURRENCY:ECA) traded 3.4% lower against the dollar during the 24-hour period ending at 18:00 PM Eastern on June 4th. Electra has a total market capitalization of $45.83 million and approximately $326,372.00 worth of Electra was traded on exchanges in the last 24 hours. One Electra coin can currently be bought for $0.0018 or 0.00000024 BTC on cryptocurrency exchanges including Novaexchange, Octaex, Fatbtc and Cryptopia. In the last seven days, Electra has traded 12.8% higher against the dollar.

• [By Keith Noonan, Travis Hoium, and Matthew DiLallo]

  We asked three Motley Fool investors to profile some of the best under-the-radar growth stocks on the market today. Read on to see why they selected Encana�(NYSE:ECA), Activision Blizzard (NASDAQ:ATVI), and Baozun (NASDAQ:BZUN) as top growth stocks for in-the-know investors.

• [By Joseph Griffin]

  These are some of the media stories that may have effected Accern’s scoring:

  Get Encana alerts: Should You Listen to This Stock? Encana Corporation (ECA) moves 51.44% away from One Year Low (nasdaqchronicle.com) Hot Mover of the Day �� Encana Corporation (NYSE:ECA) (thestockgem.com) Enrapturing Stocks: Encana Corporation, (NYSE: ECA), AmTrust Financial Services, Inc., (NASDAQ: AFSI) (globalexportlines.com) Analysts, Options Traders Love This Lesser-Known Energy Stock (schaeffersresearch.com) Encana Corp (ECA) Expected to Announce Quarterly Sales of $1.12 Billion (americanbankingnews.com)

  ECA traded up $0.27 on Thursday, hitting $12.47. 9,071,326 shares of the stock were exchanged, compared to its average volume of 9,380,907. Encana has a 12 month low of $8.01 and a 12 month high of $14.31. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $11.70 billion, a price-to-earnings ratio of 29.00, a P/E/G ratio of 1.98 and a beta of 2.00.

Hot Oil Stocks To Watch For 2019: Marathon Oil Corporation(MRO)

Advisors' Opinion:

• [By Matthew DiLallo]

  Marathon Oil (NYSE:MRO) is another oil producer built for $50 oil. At that level, Marathon can generate enough cash to grow its U.S. oil production 25% to 30% this year, while at $60 oil, the company can produce $500 million in free cash -- and even more at current prices. Marathon Oil has a range of options for that money, including buying back shares, boosting the dividend, paying off debt, or acquiring more drillable land.

• [By Matthew DiLallo]

  Marathon Oil (NYSE:MRO), likewise, said it would stick with its $2.3 billion drilling budget, which is enough money to grow oil and gas production in the U.S. by 25% to 30% versus last year. Because of that capital discipline, Marathon is on pace to produce more than $500 million in excess cash this year, and that's assuming crude averages $60 a barrel.

• [By Matthew DiLallo]

  The company's Powder River Basin�assets also generated strong drilling results, with several wells topping 1,000 BOE/D. Finally, while the company did drill four wells in the Bakken, it has deferred completing them until later this year. That program is one to keep an eye on given the results Marathon Oil (NYSE:MRO) delivered last quarter, when it completed record-setting wells in the Three Forks and Middle Bakken formations.

• [By Dan Caplinger]

  The stock market largely gained ground on Friday, although triple-digit gains for the Dow Jones Industrial Average were offset somewhat by modest losses in the Nasdaq Composite. European Union tariffs were set to take effect today on more than $3 billion in U.S. goods, representing the latest escalation in trade tensions between the U.S. and trade partners across the globe. Yet investors were ready for a break after several days of poor performance for the overall market, and good news from several companies helped set a positive mood on Wall Street. Marathon Oil (NYSE:MRO), WillScot (NASDAQ: WSC), and Del Taco Restaurants (NASDAQ:TACO) were among the best performers on the day. Here's why they did so well.

Hot Oil Stocks To Watch For 2019: Range Resources Corporation(RRC)

Advisors' Opinion:

• [By Ethan Ryder]

  OppenheimerFunds Inc. lowered its holdings in Range Resources Corp. (NYSE:RRC) by 68.2% in the first quarter, HoldingsChannel.com reports. The fund owned 30,532 shares of the oil and gas exploration company’s stock after selling 65,576 shares during the quarter. OppenheimerFunds Inc.’s holdings in Range Resources were worth $444,000 at the end of the most recent reporting period.

• [By Paul Ausick]

  Range Resources Corp. (NYSE: RRC) fell about 3.6% Monday to post a new 52-week low of $14.77 after closing at $15.30 on Friday. The 52-week high is $35.64. Volume of about 9.4 million was about 20% higher than the daily average of around 7.7 million shares traded. The company had no specific news.

• [By Paul Ausick]

  Range Resources Corp. (NYSE: RRC) fell about 4.4% Tuesday to post a new 52-week low of $14.43 after closing at $15.09 on Monday. The 52-week high is $34.93. Volume of about 15 million was nearly double the daily average of around 7.7 million shares traded. The company had no specific news.

• [By Shane Hupp]

  Toronto Dominion Bank increased its holdings in Range Resources Corp. (NYSE:RRC) by 25.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 123,421 shares of the oil and gas exploration company’s stock after purchasing an additional 24,839 shares during the period. Toronto Dominion Bank’s holdings in Range Resources were worth $1,794,000 as of its most recent SEC filing.

• [By Tyler Crowe, Matthew DiLallo, and Reuben Gregg Brewer]

  So we asked three of our investing contributors to each highlight a company they think has a compelling investment case right now in the oil and gas industry. Here's why they selected Devon Energy (NYSE:DVN), Range Resources (NYSE:RRC), and ExxonMobil (NYSE:XOM).

Everything You Need to Know About Netflix (NFLX) Ahead of Q2 Earnings

Shares of Netflix (NASDAQ:NFLX) have skyrocketed over the last year as investors continue to love the growth prospects of the streaming TV and movie giant. Now the question is what should they expect going forward from Netflix as the internet-connected TV space becomes more crowded.

Source: Shutterstock

Business & Industry Overview

Netflix might be the unquestioned streaming king at the moment, but Amazon (NASDAQ:AMZN) Prime, Hulu, and others have plans for expansion. Meanwhile, Apple (NASDAQ:AAPL) has spent heavily to scoop up an array of Hollywood talent both in front of and behind the camera for a 2019 launch of some-type of streaming TV service, with Disney’s (NYSE:DIS) much-anticipated stand-alone over-the-top streaming platform scheduled to launch in late 2019.

But the competition doesn’t seem to scare Netflix since it has anticipated the rise of streaming content and the slow death of linear, commercial-based television for years. “In a few decades, linear TV will be the fixed-line telephone: a relic,” the company wrote in its long-term outlook overview. And this is why Netflix has ramped up its original content spending for years because having programming worth paying for is really the company’s core business—a model HBO has proven for years.

Netflix noted that it expects to spend close to $8 billion on a profit and loss basis on content in 2018, while also shelling out roughly $2 billion on marketing.

The streaming company also plans to spend around $1.3 billion on technology and development this year. Some have speculated that Netflix might eventually expand beyond its current on-demand TV and movie model to offer some live news or sports, with the likes of Facebook (NASDAQ:FB), Twitter (NYSE:TWTR), and Amazon all jumping into live content. Yet, for now, Netflix maintains that it is a “movie and TV series entertainment network” and will not stream other types of video.

Netflix has landed some big names to produce new content for the platform, which will be needed to entice new customers but even more valuable for keeping current users. It is also worth noting that Netflix’s content is pretty much unlimited in duration, in the sense that a user can begin an older series, such as House of Cards, for the first time years after its debut.

Compare Brokers
Outlook

The company added 7.41 million new members in the first quarter, which marked a 50% jump from the year-ago period and topped the company’s forecast of 6.35 million. The streaming company closed the quarter with 125 million members. Looking forward, Netflix expects to add 6.2 million new members to bring its total to 131.2 million, which would represent a roughly 26% surge from the year-ago period when the company closed the quarter with 103.95 million members.

More specifically, Netflix expects to add 1.2 million new users in the U.S. to bring the total to roughly 58 million, up approximately 11.5%. The U.S. market is by far its most saturated, but the company still maintains that it can grow to between 60 to 90 million members in the U.S., based upon its trajectory to date and the continued growth of internet entertainment.

The company projects it will expand its international user base by 5 million in Q2, to hit 73.29 million,  which would mark a roughly 41% surge from the 52 million it claimed at the end of the second quarter of 2017. Netflix, which is currently available almost everywhere except China, could become even more massive if it is able to sell its service in the world’s second-largest economy. But this is certainly a big if.

Over the last month, analysts have upped their NFLX price targets in big ways. Goldman Sachs (NYSE:GS) analysts reiterated the firm’s buy rating for NFLX and upped their price target from $390 per share to $490 per share. GBH Insights upped its price target to a whopping $500 per share, less than a week after Goldman, which marked the highest out of the 36 analysts who cover Netflix, according to FactSet—shares of Netflix closed Monday at $415.63.

“Our bullish thesis on Netflix is based on our belief that the company’s competitive moat, franchise appeal, ability to increase international streaming customers through 2020, and original content build out will translate into robust profitability and growth,” GBH analyst Daniel Ives wrote in a note to clients.

Bottom Line

Our current Zacks Consensus Estimates are calling for Netflix’s Q2 revenues to surge by 41.32% to reach $3.94 billion. The company’s full-year revenues are expected to climb by nearly 38% to touch $16.12 billion.

At the other end of the income statement, Netflix’s adjusted Q2 earnings are projected to skyrocket 433% from $0.15 per share in the prior-year period to $0.80 per share. For the full-year, the company’s earnings are expected to climb by 131% to touch $2.89 per share.

Netflix is set to release its Q2 financial results after the closing bell on Monday, July 16.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2020.

Click here for the 6 t

Top 10 Clean Energy Stocks To Own For 2019

tags:CMP,JWN,COTV,ESP,CCMP,GCBC,DENN,CTMX,ADNT,PDFS,

A consortium of countries spearheaded by the United States has just formed an international pact to explore new ways to promote the responsible growth of nuclear energy. According to Deputy Secretary of Energy Dan Brouillette, the initiative seeks to "highlight the value of nuclear energy as a clean, reliable energy source."�

This new alliance was announced at a clean energy forum last week in Denmark. Other members of the pact include Argentina, Canada, Japan, Poland, Romania, Russia, South Africa and the United Arab Emirates (UAE).

My View: After the devastating destruction of Japan's Fukushima power plant in 2011, critics started writing the obituary for nuclear energy. In the years that followed, the industry was indeed battered and bruised. Amid mounting opposition, some nuclear plants went into early retirement, while new construction projects around the globe were postponed or scrapped.�

A number of countries decided to gradually phase out nuclear energy altogether. Germany, for example, has reduced its dependency from 25% of the power grid (17 reactors) in 2011 to just 12% (seven reactors) today. Just look at a long-term chart of uranium prices, and it's easy to see the damage inflicted by changing government policies.�

Top 10 Clean Energy Stocks To Own For 2019: Compass Minerals Intl Inc(CMP)

Advisors' Opinion:

• [By Ethan Ryder]

  Compass Minerals International (NYSE:CMP) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Monday.

Top 10 Clean Energy Stocks To Own For 2019: Nordstrom Inc.(JWN)

Advisors' Opinion:

• [By JJ Kinahan]

  It’s all retail all the time this week, with Kohl’s Corporation (NYSE: KSS), Target Corporation (NYSE: TGT), Lowe’s Companies, Inc. (NYSE: LOW), Gap Inc. (NYSE: GPS), Foot Locker, Inc. (NYSE: FL), and Tiffany & Co (NYSE: TIF) among the big names scheduled to report. Last week saw mixed signals from retailers, with Macy’s Inc. (NYSE: M) and Walmart Inc. (NYSE: WMT) both delivering impressive results while J.C. Penney Company Inc. (NYSE: JCP) and Nordstrom, Inc. (NYSE: JWN) received poor reviews from the Street. TGT is arguably the biggest one to watch in the days ahead (see more detail below).

• [By Chris Lange]

  Look for Nordstrom Inc. (NYSE: JWN) to reveal its fiscal fourth-quarter results on Thursday as well. The consensus analyst estimates are $1.25 in EPS and revenue of $4.62 billion. Shares of Nordstrom closed at $53.56 on Friday, above the consensus price target of $49.94. The 52-week range is $37.79 to $54.00.

• [By Chris Lange]

  Nordstrom Inc.’s (NYSE: JWN) most recent quarterly release is anticipated late on Thursday. The consensus forecast is $0.44 in EPS on $3.46 billion in revenue. Shares ended the week at $48.80. The consensus target price is $51.19, and the 52-week range is $37.79 to $54.00.

Top 10 Clean Energy Stocks To Own For 2019: Cotiviti Holdings, Inc. (COTV)

Advisors' Opinion:

• [By Steve Symington]

  Shares of Cotiviti Holdings Inc.�(NYSE:COTV) were up 10.2% as of 1:00 p.m. EDT Tuesday after Veritas Capital agreed to acquire the healthcare payment solutions company.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Cotiviti (COTV)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Cotiviti Holdings, Inc. (NYSE:COTV) – Equities research analysts at Jefferies Group lowered their FY2018 earnings estimates for Cotiviti in a report issued on Wednesday, May 2nd. Jefferies Group analyst S. Dodge now expects that the business services provider will post earnings per share of $1.68 for the year, down from their previous estimate of $1.71. Jefferies Group also issued estimates for Cotiviti’s FY2019 earnings at $1.87 EPS.

Top 10 Clean Energy Stocks To Own For 2019: Espey Mfg. & Electronics Corp.(ESP)

Advisors' Opinion:

• [By Stephan Byrd]

  Espers (CURRENCY:ESP) traded up 5.2% against the US dollar during the one day period ending at 7:00 AM Eastern on May 28th. Espers has a market capitalization of $6.27 million and approximately $8,492.00 worth of Espers was traded on exchanges in the last 24 hours. One Espers coin can now be bought for about $0.0003 or 0.00000004 BTC on cryptocurrency exchanges including Livecoin and CoinExchange. During the last seven days, Espers has traded down 26.2% against the US dollar.

• [By Ethan Ryder]

  Espers (ESP) is a PoW/PoS coin that uses the HMQ1725 hashing algorithm. It was first traded on April 28th, 2016. Espers’ total supply is 21,802,827,290 coins. The Reddit community for Espers is /r/esperscoin and the currency’s Github account can be viewed here. Espers’ official Twitter account is @CryptoCoderz and its Facebook page is accessible here. Espers’ official website is espers.io.

Top 10 Clean Energy Stocks To Own For 2019: Cabot Microelectronics Corporation(CCMP)

Advisors' Opinion:

• [By Logan Wallace]

  Cabot Microelectronics (NASDAQ: CCMP) and Analog Devices (NASDAQ:ADI) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

• [By Ethan Ryder]

  Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $112.25.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Cabot Microelectronics (CCMP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  News coverage about Cabot Microelectronics (NASDAQ:CCMP) has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cabot Microelectronics earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.640513544039 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

• [By Max Byerly]

  Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $114.80.

Top 10 Clean Energy Stocks To Own For 2019: Greene County Bancorp, Inc.(GCBC)

Advisors' Opinion:

• [By Joseph Griffin]

  BidaskClub upgraded shares of Greene County Bancorp (NASDAQ:GCBC) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday.

Top 10 Clean Energy Stocks To Own For 2019: Denny's Corporation(DENN)

Advisors' Opinion:

• [By Max Byerly]

  News articles about Denny’s (NASDAQ:DENN) have trended somewhat negative this week, according to Accern Sentiment. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Denny’s earned a media sentiment score of -0.06 on Accern’s scale. Accern also gave media stories about the restaurant operator an impact score of 43.0997571340278 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Clean Energy Stocks To Own For 2019: CytomX Therapeutics, Inc.(CTMX)

Advisors' Opinion:

• [By Shane Hupp]

  Shares of CytomX Therapeutics (NASDAQ:CTMX) have earned an average recommendation of “Buy” from the thirteen research firms that are currently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $39.86.

• [By Logan Wallace]

  Shares of CytomX Therapeutics (NASDAQ:CTMX) have received an average recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $40.17.

• [By Lisa Levin] Gainers Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'. CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting. Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss. Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session. Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results. World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading. Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal. Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday. Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday. Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday. Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

   

• [By Ethan Ryder]

  CytomX Therapeutics Inc (NASDAQ:CTMX) CEO Sean A. Mccarthy sold 2,028 shares of the company’s stock in a transaction on Tuesday, July 3rd. The shares were sold at an average price of $25.09, for a total transaction of $50,882.52. Following the completion of the sale, the chief executive officer now owns 84,091 shares of the company’s stock, valued at approximately $2,109,843.19. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Top 10 Clean Energy Stocks To Own For 2019: Adient plc (ADNT)

Advisors' Opinion:

• [By Chris Lange]

  Adient PLC (NYSE: ADNT) was one of Monday morning��s worst performing stocks, after it was announced that its Chairman and CEO would be stepping down effective immediately. Also the company issued a revised outlook for the 2018 full year that was not up to par.

• [By Dan Caplinger]

  Monday was another positive day for the stock market, with major benchmarks seeing small advances to start the week. Most investors focused on Singapore, where U.S. President Donald Trump is expected to meet with North Korean leader Kim Jong Un. Geopolitical issues have weighed on market sentiment for some time, so any sort of favorable resolution to tensions on the nuclear front could be embraced by Wall Street. Still, some companies had bad news today that held back their shares. Adient (NYSE:ADNT), CRISPR Therapeutics (NASDAQ:CRSP), and Applied Optoelectronics (NASDAQ:AAOI) were among the worst performers on the day. Here's why they did so poorly.

• [By Daniel Sparks]

  Shares of vehicle seat system manufacturer Adient (NYSE:ADNT) fell as much as 17.5% on Monday, following a press release from the company detailing the resignation of its CEO and a lowered outlook for fiscal 2018 profitability.

Top 10 Clean Energy Stocks To Own For 2019: PDF Solutions Inc.(PDFS)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on PDF Solutions (PDFS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  ValuEngine upgraded shares of PDF Solutions (NASDAQ:PDFS) from a strong sell rating to a sell rating in a report released on Tuesday.

  PDFS has been the topic of a number of other research reports. Zacks Investment Research upgraded PDF Solutions from a sell rating to a hold rating in a research report on Wednesday, March 14th. BidaskClub upgraded PDF Solutions from a sell rating to a hold rating in a research report on Wednesday, May 9th. Finally, DA Davidson reduced their price objective on PDF Solutions to $26.00 and set a buy rating on the stock in a research report on Friday, February 16th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $22.00.

• [By Joseph Griffin]

  These are some of the media headlines that may have effected Accern Sentiment’s scoring:

  Get PDF Solutions alerts: FlipHTML5 Page Flip PDF Turns Social Media Accounts Into Compelling Ones (digitaljournal.com) $23.10 Million in Sales Expected for PDF Solutions, Inc. (PDFS) This Quarter (americanbankingnews.com) PDF Solutions, Inc. (PDFS) Expected to Announce Earnings of $0.06 Per Share (americanbankingnews.com) Basware introduces a ��Smart PDF�� invoice (itwire.com) ActivePDF Brings Redaction to Businesses, Improving Privacy, Security,�� (virtual-strategy.com)

  A number of equities research analysts have recently commented on PDFS shares. Zacks Investment Research cut shares of PDF Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, May 16th. DA Davidson cut their price target on shares of PDF Solutions to $26.00 and set a “buy” rating on the stock in a report on Friday, February 16th. BidaskClub upgraded shares of PDF Solutions from a “strong sell” rating to a “sell” rating in a report on Thursday, May 3rd. Finally, ValuEngine cut shares of PDF Solutions from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $22.00.

Cramer: The real cause of the bank stocks' weakness isn't the yield curve��it's trade

For CNBC's Jim Cramer, the biggest shocker of Monday's rally wasn't the Dow Jones Industrial Average's 300-plus-point climb or the market's ability to shrug off trade war fears. It was the bank stocks' performance.

The rallies in shares of J.P. Morgan Chase, Citigroup, Wells Fargo, Bank of America, Goldman Sachs and Morgan Stanley sent the financial sector up at least 2.5 percent. Monday marked the best day for the cohort since March 26, based on the SPDR S&P Bank ETF (KBE).

"There's nothing like a big up day to find out what's really going on," the "Mad Money" host said on Monday.

Until recently, much of Wall Street was writing off the bank stocks' weakness as a casualty of the flattening yield curve, Cramer said. Money managers were making the calculation that if interest rates were similar for long-term and short-term loans, banks would shy away from longer-term lending, a key line of business for the big banks.

"However, today��s stunning action suggests that China��s been weighing far more heavily on the banks than we thought," Cramer said. "We can only conclude that these stocks have also been caught up in the world trade woes."

Last Thursday, the United States and China exchanged $34 billion worth of tariffs on each other's goods, escalating their tit-for-tat spat to trade war levels.

The move put pressure on much of the market ahead of Friday's non-farm employment report from the U.S. Labor Department, which provided some momentary reprieve for stocks knocked off their highs by tariff worries.

But as the bank cohort rallied on Monday after several days of calm in the Washington-Beijing trade dispute, Cramer realized that the banks, too, had been dragged into the global economic conflict.

"That��s right, despite the fact that volatility from the ebb and flow of trade is good for the investment banks, it��s clear that investors perceive these stocks as being levered to the global economic expansion �� same thing goes for the trading arms of the regular banks �� and that expansion is jeopardized by tariffs and trade barriers," the "Mad Money" host said.

But Cramer wasn't exactly on board with that theory.

He said that Wells Fargo �� shares of which rose 1.57 percent in Monday's trading session �� had little international exposure and was primed for an "excellent" earnings report on Friday. He also highlighted Citigroup as a particularly good buy due to its 7 percent share buyback.

"The banks are the cheapest relative to their earnings I have seen in almost 40 years of investing," Cramer said. "What is the deal?"

"I don��t think people recognize how much money the banks can make in this environment or how well they��ve tended to trade after the Fed��s annual stress tests," he added. "My judgment? The big banks are all buys."

And even after Monday's rally, Cramer suggested circling back to high-quality prospects like these to find the ones trading at deep discounts.

WATCH: Cramer deciphers Monday's rally show chapters Cramer: The real cause of the bank stocks' weakness isn't the yield curve—it's trade    49 Mins Ago | 11:08

Disclosure: Cramer's charitable trust owns shares of J.P. Morgan Chase, Citigroup and Goldman Sachs.

Questions for Cramer? Call Cramer: 1-800-743-CNBC Want to take a deep dive into Cramer's world? Hit him up! Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Top Value Stocks To Own Right Now

tags:PAG,CCJ,CATY,

There are dozens of large-cap value exchange-traded funds for value investors to consider. One of the most venerable is the Vanguard Value ETF (NYSE: VTV).

VTV, which tracks the CRSP US Large Cap Value Index, is beloved among value investors for several reasons, not the least of which is its low fee. The Vanguard fund charges just 0.05 percent per year, the equivalent of $5 on a $10,000 investment. That makes VTV less expensive than 95 percent of competing value strategies, according to issuer data.

What Happened

On a historical basis, value stocks often outperform their growth and momentum counterparts with less volatility over long holdings periods. However, during the course of the current bull market in U.S. stocks, the value factor is lagging growth and momentum.

Over the past three years, VTV is trailing its growth counterpart, the Vanguard Growth ETF (NYSE: VUG), by nearly 1,000 basis points. During the same period, VTV has delivered barely more than half the returns of the growth-oriented Nasdaq-100 Index.

Why It's Important

“Large-value stocks tend to be mature businesses that are often trading at low valuations for good reason, including slow expected growth and, in some cases, high business risk,” said Morningstar in a note on VTV last Friday.

Top Value Stocks To Own Right Now: Penske Automotive Group, Inc.(PAG)

Advisors' Opinion:

• [By Shane Hupp]

  Penske Automotive Group (NYSE: PAG) is one of 20 publicly-traded companies in the “Automotive dealers & gasoline service stations” industry, but how does it compare to its peers? We will compare Penske Automotive Group to similar companies based on the strength of its earnings, valuation, institutional ownership, dividends, analyst recommendations, risk and profitability.

• [By Lisa Levin] Companies Reporting Before The Bell Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion. Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion. Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million. Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion. General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion. The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion. Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion. Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion. Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion. Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion. Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion. The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion. Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion. T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion. Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion. Sirius XM Holdings Inc. (NASDAQ: SI
• [By John Rosevear]

  Daimler said that two companies that operate fleets of big trucks have signed up to participate in the pilot program for the two new electric trucks being developed by its Freightliner brand:

  Penske Truck Leasing is a corporate sibling of Penske Automotive Group (NYSE:PAG) that leases and maintains over 240,000 trucks around the world. NFI Industries is a full-service logistics company, a freight hauler that operates a fleet of over 4,000 tractors and 8,700 trailers.

  Daimler said that it will supply Penske and NFI with a test fleet of 30 prototype electric trucks before the end of the year. The two companies will evaluate the new Freightliners, working closely with Freightliner engineers to provide detailed feedback to help the company refine the trucks' designs.

Top Value Stocks To Own Right Now: Cameco Corporation(CCJ)

Advisors' Opinion:

• [By Neha Chamaria]

  The uranium industry is at an interesting juncture right now. Leading uranium miners like Cameco Corporation (NYSE:CCJ) are going all out to help rebalance the demand and supply in the market as the debate over the potential dangers of nuclear power reactors, spurred by Japan's Fukushima Daiichi disaster of 2011, continues. (Nuclear reactors are key users of uranium fuel.)

• [By Neha Chamaria]

  Gitzel's quote above from Cameco's (NYSE:CCJ) recent quarterly earnings release pretty much sums up what's happening at the uranium mining giant.

  As a nuclear fuel pure-play, Cameco was among the worst-hit companies when the 2011 Fukushima Daiichi nuclear disaster in Japan brought the construction of nuclear reactors worldwide to a grinding halt. Japan shuttered all of its more than 50 reactors, nations across the globe mothballed projects, demand and prices of uranium slumped, and the uranium industry is still trying to find its feet.�

• [By Max Byerly]

  Cameco (NYSE: CCJ) and Abtech (OTCMKTS:ABHD) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

• [By Peter Graham]

  This morning before the market opened, uranium producer Cameco Corporation (NYSE: CCJ) reported Q1 2018 results which should be looked over by investors in other potential�uranium players like small cap Azincourt Energy Corp (TSX-V: AAZ; OTCMKTS: AZURF) as CCJ�would be one of the world��s largest uranium producers, a significant supplier of conversion services and one of two Candufuel manufacturers in Canada. Cameco Corporation also�says its�competitive position is based on�controlling ownership of the world��s largest high-grade reserves and low-cost operations.�

• [By Reuben Gregg Brewer]

  Cameco Corporation (NYSE:CCJ), the largest publicly traded uranium miner, has been struggling along with the moribund price of the nuclear fuel it mines. The stock is down over 70% since commodity markets started to tumble in 2011. The early 2016 commodity upturn, meanwhile, has seemingly left uranium behind. Investors have ample reason to worry, but for more intrepid stock buyers, Cameco's low stock price could be a long-term opportunity.

Top Value Stocks To Own Right Now: Cathay General Bancorp(CATY)

Advisors' Opinion:

• [By Stephan Byrd]

  Allianz Asset Management GmbH boosted its stake in Cathay General Bancorp (NASDAQ:CATY) by 461.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 28,806 shares of the bank’s stock after purchasing an additional 23,672 shares during the quarter. Allianz Asset Management GmbH’s holdings in Cathay General Bancorp were worth $1,152,000 as of its most recent filing with the SEC.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Heal Care Stocks To Watch For 2019

tags:MGM,WMIH,GGB, To make your portfolio safer, reach across the globe.

Big caps, small caps, bonds, a touch of international stocks—you think you’re diversified. You probably aren’t. How much have you allocated to British real estate? Where’s your gold?

Investors make two very big mistakes when they put together a portfolio, says money manager Randy D. Kurtz. One is their home bias. Japanese investors buy mostly Japanese stocks and U.S. investors U.S. stocks, missing the greater stability that comes from a cosmopolitan collection of assets.

“It doesn’t matter where you live. You should have the best portfolio,” Kurtz says.

The other mistake is to favor what has worked in the recent past. In 1989, people piled into Japanese equities, then sizzling. Now they love the U.S. stock market, the hot category over the past five years. They should be going the other direction. Kurtz tells U.S. investors (and Japanese investors, if they are listening) to have only 11% of their assets in U.S. stocks.

Hot Heal Care Stocks To Watch For 2019: MGM Resorts International(MGM)

Advisors' Opinion:

• [By Ethan Ryder]

  These are some of the news articles that may have impacted Accern’s scoring:

  Get Xilinx alerts: Stochastic Oscillator Analysis for Xilinx Inc. (NASDAQ:XLNX) (oracleexaminer.com) Stocks Buzz- MGM Resorts International (NYSE:MGM), Xilinx, Inc. (NASDAQ:XLNX), Darling Ingredients Inc. (NYSE:DAR) (journalfinance.net) Fast-Moving Stocks: Broadcom Inc. (NASDAQ:AVGO), Xilinx, Inc. (NASDAQ:XLNX), Casa Systems, Inc. (NASDAQ … (thestreetpoint.com) Solarflare and LDA Technologies Racing to near Zero Latency, Achieve 120 Nanosecond CME Tick-To-Trade Network Latency (markets.financialcontent.com) What 20-Day Moving Average Analysis say about Xilinx Inc. (NASDAQ:XLNX)? (oracleexaminer.com)

  Several research firms have recently commented on XLNX. JPMorgan Chase upped their target price on Xilinx from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Thursday, April 26th. Mizuho reaffirmed a “buy” rating and issued a $74.00 target price (up previously from $69.00) on shares of Xilinx in a research report on Thursday, January 25th. SunTrust Banks upped their target price on Xilinx to $79.00 and gave the company an “outperform” rating in a research report on Thursday, January 25th. Macquarie decreased their target price on Xilinx from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Thursday, April 26th. Finally, Wells Fargo upped their target price on Xilinx from $66.00 to $70.00 and gave the company a “market perform” rating in a research report on Thursday, January 25th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and ten have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $73.20.

• [By Travis Hoium]

  Amid these legal challenges, Bloomberg and�The Wall Street Journal�(subscription required) have reported that Wynn Resorts has considered selling Encore Boston Harbor to MGM Resorts (NYSE:MGM), the other gaming license holder in Massachusetts. A sale would be complex given what Wynn Resorts has already spent and the MGM Springfield site MGM Resorts has nearly opened (which would most likely need to be sold), but Maddox may want to get rid of the headache.�

• [By ]

  Melco Resorts (MLCO) : "No, no, I like MGM Resorts (MGM) ."

  Oracle (ORCL) : "I think Oracle is fine, but I still favor Salesforce.com (CRM) ."

• [By ]

  Cramer said that Everi (EVRI) has been a roller coaster and is too risky for most investors. He recommended his favorite in the casino space, MGM Resorts (MGM) .

Hot Heal Care Stocks To Watch For 2019: WMIH Corp.(WMIH)

Advisors' Opinion:

• [By Stephan Byrd]

  Medallion Financial (NASDAQ: MFIN) and WMIH (NASDAQ:WMIH) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, analyst recommendations, profitability and dividends.

• [By Max Byerly]

  News stories about WMIH (NASDAQ:WMIH) have trended somewhat positive on Friday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. WMIH earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.1981961674374 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

• [By Max Byerly]

  These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

  Get Innovative Industrial Properties alerts: Return on Equity (ROE) under Consideration Innovative Industrial Properties, Inc. (NYSE:IIPR), Neonode Inc … (stocksnewspoint.com) Morning Miraculous Stocks: Taseko Mines Limited (NYSE:TGB), WMIH Corp. (NASDAQ:WMIH), Innovative Industrial … (journalfinance.net) Dazzling Stocks: Innovative Industrial Properties, Inc. (NYSE:IIPR), SORL Auto Parts, Inc. (NASDAQ:SORL), ReWalk … (thestreetpoint.com) Head-To-Head Contrast: Kennedy-Wilson (KW) vs. Innovative Industrial Properties (IIPR) (americanbankingnews.com) Innovative Industrial (IIPR) versus Colliers International Group (CIGI) Financial Contrast (americanbankingnews.com)

  A number of research analysts have weighed in on the company. Zacks Investment Research raised Innovative Industrial Properties from a “sell” rating to a “hold” rating in a report on Friday, March 16th. ValuEngine raised Innovative Industrial Properties from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd.

Hot Heal Care Stocks To Watch For 2019: Gerdau S.A.(GGB)

Advisors' Opinion:

• [By Max Byerly]

  Gerdau (NYSE:GGB) fell 7.6% on Tuesday . The stock traded as low as $3.99 and last traded at $4.00. 20,132,700 shares were traded during mid-day trading, an increase of 80% from the average session volume of 11,155,967 shares. The stock had previously closed at $4.33.

• [By Matthew DiLallo]

  Shares of Gerdau (NYSE:GGB) tumbled more than 10% by 2:45 p.m. EDT Thursday in what was a tumultuous day for stocks in Brazil. The Brazil-based steel company sold off along with that country's stock market amid fears that the recent trucker strike could have a deep impact on the economy.

• [By Shane Hupp]

  AMG Funds LLC lessened its stake in Gerdau (NYSE:GGB) by 12.1% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 256,979 shares of the basic materials company’s stock after selling 35,501 shares during the quarter. AMG Funds LLC’s holdings in Gerdau were worth $1,198,000 at the end of the most recent reporting period.

• [By Logan Wallace]

  Gerdau (NYSE:GGB) has been assigned an average recommendation of “Buy” from the eleven analysts that are currently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $4.00.

Nabriva Therapeutics (NBRV) Reaches New 52-Week Low at $4.20

Nabriva Therapeutics PLC – (NASDAQ:NBRV) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $4.20 and last traded at $4.39, with a volume of 8914 shares. The stock had previously closed at $4.29.

A number of brokerages have recently issued reports on NBRV. ValuEngine upgraded shares of Nabriva Therapeutics from a “sell” rating to a “hold” rating in a research note on Tuesday, May 22nd. Cantor Fitzgerald set a $16.00 price target on shares of Nabriva Therapeutics and gave the stock a “buy” rating in a research note on Wednesday, May 30th. Needham & Company LLC reiterated a “buy” rating and set a $18.00 price target on shares of Nabriva Therapeutics in a research note on Tuesday, May 8th. Wedbush reiterated an “outperform” rating on shares of Nabriva Therapeutics in a research note on Monday, March 19th. Finally, Northland Securities began coverage on shares of Nabriva Therapeutics in a research note on Thursday, May 31st. They set an “outperform” rating on the stock. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Nabriva Therapeutics currently has an average rating of “Buy” and a consensus price target of $16.81.

Get Nabriva Therapeutics alerts:

The stock has a market capitalization of $176.58 million, a price-to-earnings ratio of -1.54 and a beta of 1.74.

Nabriva Therapeutics (NASDAQ:NBRV) last issued its earnings results on Tuesday, May 8th. The biotechnology company reported ($0.36) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.23. Nabriva Therapeutics had a negative net margin of 600.34% and a negative return on equity of 79.30%. The company had revenue of $7.55 million for the quarter, compared to analyst estimates of $1.27 million. sell-side analysts expect that Nabriva Therapeutics PLC – will post -1.82 earnings per share for the current fiscal year.

In other Nabriva Therapeutics news, Director Stephen W. Webster purchased 8,000 shares of the stock in a transaction dated Wednesday, May 23rd. The shares were acquired at an average cost of $4.59 per share, for a total transaction of $36,720.00. Following the completion of the transaction, the director now directly owns 8,000 shares of the company’s stock, valued at $36,720. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, General Counsel Robert Crotty purchased 10,000 shares of the stock in a transaction dated Wednesday, May 23rd. The stock was acquired at an average price of $4.48 per share, for a total transaction of $44,800.00. Following the completion of the transaction, the general counsel now directly owns 10,000 shares of the company’s stock, valued at $44,800. The disclosure for this purchase can be found here. Insiders have acquired 22,160 shares of company stock worth $100,596 over the last 90 days. 2.75% of the stock is currently owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in NBRV. DRW Securities LLC acquired a new stake in shares of Nabriva Therapeutics in the first quarter valued at approximately $106,000. JPMorgan Chase & Co. grew its position in shares of Nabriva Therapeutics by 163.9% in the first quarter. JPMorgan Chase & Co. now owns 24,959 shares of the biotechnology company’s stock valued at $126,000 after purchasing an additional 15,501 shares during the last quarter. Trexquant Investment LP acquired a new stake in shares of Nabriva Therapeutics in the first quarter valued at approximately $244,000. Virtu Financial LLC acquired a new stake in shares of Nabriva Therapeutics in the fourth quarter valued at approximately $429,000. Finally, Dimensional Fund Advisors LP grew its position in shares of Nabriva Therapeutics by 173.2% in the first quarter. Dimensional Fund Advisors LP now owns 111,865 shares of the biotechnology company’s stock valued at $563,000 after purchasing an additional 70,917 shares during the last quarter. Institutional investors and hedge funds own 68.88% of the company’s stock.

Nabriva Therapeutics Company Profile

Nabriva Therapeutics plc, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which is in Phase III clinical trials in intravenous and oral formulations for the treatment of community-acquired bacterial pneumonia; and has completed Phase II clinical trials for the treatment of acute bacterial skin and skin structure infection.

Tesla Autopilot ��Nag Reduction Device�� Targeted by U.S. Agency

LISTEN TO ARTICLE 2:29 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

The Autopilot Buddy is marketed as a “nag reduction device” that can fool Tesla Inc.’s semi-autonomous driving system to circumvent a warning when a driver’s hands aren’t on the steering wheel, but U.S. regulators have another term for the product: “unacceptable.”

The U.S. National Highway Traffic Safety Administration on Tuesday said it was ordering the aftermarket device maker to cease selling the Autopilot Buddy because it could put drivers and others at risk.

A letter sent by NHTSA to the company, identified on the website autopilotbuddy.com as Dolder, Falco and Reese Partners LLC, orders it to respond by June 29 and certify that distribution and marketing of the product has ended. The company is not affiliated with Tesla.

The Autopilot Buddy website promises to reduce Tesla’s “nagging reminders” to drivers that they need to put their hands on the wheel in order to allow customers to "enjoy autopilot."

Despite those promises, NHTSA found the product “is intended to circumvent motor vehicle safety and driver attentiveness” NHTSA Deputy Administrator Heidi King said in a press release. “By preventing the safety system from warning the driver to return hands to the wheel, this product disables an important safeguard, and could put customers and other road users at risk.”

Just How Safe Is Driverless Car Technology, Really?: QuickTake

A Tesla spokesman said the company supports NHTSA’s action to force the company to end sales of the device.

While fully self-driving cars are still in development, several carmakers including Tesla and General Motors Co. have developed suites of technology that automatically keep cars in their lanes and follow the vehicle ahead at a safe distance.

The companies require drivers to keep their hands on the steering wheel, even if the cars are at times largely driving themselves. In the case of the Tesla, the system monitors steering wheel movements to assess whether the driver is engaged.

Despite the Autopilot Buddy website’s assertion that the hands-off warnings are an impediment to owners, it also maintains a disclaimer saying: "This is not intended to be a hands-off device, your hands must remain on the wheel as directed by Tesla’s terms of ‘Autosteer’ user agreement."

A spate of crashes involving Teslas has thrust the issue of semi-autonomous driving features into the news. The National Transportation Safety Board is looking at a March 23 accident in California in which the system didn’t detect the driver’s hands on the wheel when it struck a highway barrier and killed him.

Autopilot Buddy’s website currently discloses that it is no longer taking orders inside the U.S. Dolder, Falco and Reese is registered to Carl Reese in California. A phone message and email to Reese asking for comment were not immediately returned.

— With assistance by Alan Levin, and Ryan Beene

Navigator Holdings Ltd (NVGS) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Navigator Holdings Ltd (NYSE:NVGS) have earned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $15.00.

Several analysts recently weighed in on the company. ValuEngine raised Navigator from a “hold” rating to a “buy” rating in a research note on Thursday, May 31st. Maxim Group reiterated a “buy” rating and issued a $16.00 target price (up from $14.50) on shares of Navigator in a research report on Monday, March 5th. Finally, Zacks Investment Research upgraded Navigator from a “sell” rating to a “hold” rating in a research report on Tuesday, February 20th.

Get Navigator alerts:

A number of institutional investors have recently bought and sold shares of the business. Wells Fargo & Company MN grew its stake in Navigator by 218.9% during the fourth quarter. Wells Fargo & Company MN now owns 989,591 shares of the shipping company’s stock worth $9,748,000 after purchasing an additional 679,250 shares during the period. Penbrook Management LLC purchased a new position in Navigator during the fourth quarter worth about $1,481,000. Oppenheimer & Co. Inc. grew its position in Navigator by 2.4% during the first quarter. Oppenheimer & Co. Inc. now owns 1,577,539 shares of the shipping company’s stock worth $18,536,000 after buying an additional 37,460 shares in the last quarter. Frontier Capital Management Co. LLC grew its position in Navigator by 34.1% during the first quarter. Frontier Capital Management Co. LLC now owns 916,118 shares of the shipping company’s stock worth $10,764,000 after buying an additional 233,178 shares in the last quarter. Finally, BancorpSouth Bank purchased a new position in Navigator during the first quarter worth about $411,000. Hedge funds and other institutional investors own 68.70% of the company’s stock.

Shares of Navigator traded up $0.12, hitting $11.03, during mid-day trading on Monday, MarketBeat Ratings reports. The stock had a trading volume of 33,351 shares, compared to its average volume of 100,428. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.90 and a quick ratio of 0.82. Navigator has a 12-month low of $7.00 and a 12-month high of $13.25. The stock has a market cap of $605.30 million, a price-to-earnings ratio of 68.91, a price-to-earnings-growth ratio of 4.55 and a beta of 1.22.

Navigator (NYSE:NVGS) last released its earnings results on Wednesday, May 9th. The shipping company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.05). The company had revenue of $77.81 million for the quarter, compared to analyst estimates of $62.22 million. Navigator had a return on equity of 0.34% and a net margin of 1.09%. The business’s revenue for the quarter was up .6% compared to the same quarter last year. During the same period last year, the company posted $0.05 earnings per share. equities analysts expect that Navigator will post 0.27 earnings per share for the current fiscal year.

About Navigator

Navigator Holdings Ltd. owns and operates a fleet of liquefied gas carriers worldwide. The company provides international and regional seaborne transportation services of liquefied petroleum gas, petrochemical gases, and ammonia for energy companies, industrial users, and commodity traders. As of December 31, 2017, it owned and operated a fleet of 38 vessels.

Acuity Brands, Inc. (AYI) Stake Boosted by BlackRock Inc.

BlackRock Inc. lifted its stake in shares of Acuity Brands, Inc. (NYSE:AYI) by 1.8% during the first quarter, HoldingsChannel.com reports. The firm owned 2,839,265 shares of the electronics maker’s stock after purchasing an additional 50,931 shares during the period. BlackRock Inc. owned 0.07% of Acuity Brands worth $395,201,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Glen Harbor Capital Management LLC grew its stake in shares of Acuity Brands by 11.4% during the 1st quarter. Glen Harbor Capital Management LLC now owns 4,658 shares of the electronics maker’s stock worth $648,000 after purchasing an additional 476 shares during the period. KBC Group NV grew its stake in shares of Acuity Brands by 861.7% during the 1st quarter. KBC Group NV now owns 87,448 shares of the electronics maker’s stock worth $12,171,000 after purchasing an additional 78,355 shares during the period. Eagle Asset Management Inc. grew its stake in shares of Acuity Brands by 6.1% during the 1st quarter. Eagle Asset Management Inc. now owns 481,724 shares of the electronics maker’s stock worth $67,051,000 after purchasing an additional 27,600 shares during the period. Korea Investment CORP grew its stake in shares of Acuity Brands by 53.5% during the 1st quarter. Korea Investment CORP now owns 31,006 shares of the electronics maker’s stock worth $4,316,000 after purchasing an additional 10,806 shares during the period. Finally, Penserra Capital Management LLC grew its stake in shares of Acuity Brands by 57.1% during the 1st quarter. Penserra Capital Management LLC now owns 1,650 shares of the electronics maker’s stock worth $214,000 after purchasing an additional 600 shares during the period.

Get Acuity Brands alerts:

AYI has been the topic of a number of recent analyst reports. ValuEngine cut shares of Acuity Brands from a “hold” rating to a “sell” rating in a research note on Monday, April 2nd. Roth Capital set a $105.00 price objective on shares of Acuity Brands and gave the company a “sell” rating in a research note on Monday, April 2nd. Robert W. Baird reissued a “hold” rating and issued a $168.00 price objective on shares of Acuity Brands in a research note on Friday, March 16th. Williams Capital lowered their price objective on shares of Acuity Brands from $175.00 to $151.00 and set a “hold” rating on the stock in a research note on Thursday, April 5th. Finally, JMP Securities raised shares of Acuity Brands from a “market perform” rating to an “outperform” rating and set a $150.00 price objective on the stock in a research note on Thursday, April 5th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. Acuity Brands has a consensus rating of “Hold” and a consensus target price of $177.82.

Shares of Acuity Brands opened at $121.50 on Friday, according to MarketBeat Ratings. The stock has a market capitalization of $5.02 billion, a P/E ratio of 15.26, a price-to-earnings-growth ratio of 1.57 and a beta of 1.33. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.51 and a current ratio of 2.15. Acuity Brands, Inc. has a 52 week low of $109.98 and a 52 week high of $208.82.

Acuity Brands (NYSE:AYI) last released its earnings results on Wednesday, April 4th. The electronics maker reported $1.89 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.95 by ($0.06). The firm had revenue of $832.10 million during the quarter, compared to analysts’ expectations of $799.33 million. Acuity Brands had a net margin of 9.68% and a return on equity of 20.56%. Acuity Brands’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.77 earnings per share. equities research analysts expect that Acuity Brands, Inc. will post 7.99 earnings per share for the current year.

Acuity Brands declared that its board has initiated a share buyback plan on Wednesday, April 4th that permits the company to repurchase 6,000,000 outstanding shares. This repurchase authorization permits the electronics maker to purchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

In other news, Director W. Patrick Battle bought 1,330 shares of Acuity Brands stock in a transaction on Thursday, May 3rd. The shares were bought at an average cost of $112.91 per share, for a total transaction of $150,170.30. Following the acquisition, the director now owns 2,809 shares in the company, valued at $317,164.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director George Douglas Dillard, Jr. bought 5,000 shares of Acuity Brands stock in a transaction on Tuesday, May 8th. The stock was purchased at an average price of $112.76 per share, for a total transaction of $563,800.00. The disclosure for this purchase can be found here. 1.50% of the stock is currently owned by corporate insiders.

Acuity Brands Profile

Acuity Brands, Inc provides lighting and building management solutions and services for commercial, institutional, industrial, infrastructure, and residential applications in North America and internationally. The company offers lighting and controls products and solutions, such as recessed, surface, and suspended lighting; down, decorative, emergency and exit, track, day, special-use, street and roadway, parking garage, landscape, and underwater lighting; area pedestrian, flood, and decorative site lighting; occupancy sensors; photo controls; relay panels; architectural dimming panels; and integrated lighting controls systems.

Want to see what other hedge funds are holding AYI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acuity Brands, Inc. (NYSE:AYI).

OppenheimerFunds Inc. Has $300.88 Million Position in Eastman Chemical (EMN)

OppenheimerFunds Inc. increased its stake in Eastman Chemical (NYSE:EMN) by 13.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,849,739 shares of the basic materials company’s stock after purchasing an additional 346,667 shares during the quarter. OppenheimerFunds Inc. owned approximately 2.00% of Eastman Chemical worth $300,875,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of EMN. Balter Liquid Alternatives LLC purchased a new position in Eastman Chemical in the 4th quarter worth about $115,000. Advisors Preferred LLC purchased a new position in Eastman Chemical in the 4th quarter worth about $120,000. NuWave Investment Management LLC purchased a new position in Eastman Chemical in the 4th quarter worth about $123,000. Vigilant Capital Management LLC purchased a new position in Eastman Chemical in the 4th quarter worth about $126,000. Finally, Avestar Capital LLC purchased a new position in Eastman Chemical in the 4th quarter worth about $129,000. 83.87% of the stock is currently owned by hedge funds and other institutional investors.

Get Eastman Chemical alerts:

A number of equities analysts recently weighed in on EMN shares. Zacks Investment Research raised Eastman Chemical from a “hold” rating to a “buy” rating and set a $114.00 price target on the stock in a research note on Wednesday, May 2nd. ValuEngine cut Eastman Chemical from a “strong-buy” rating to a “buy” rating in a research note on Monday, April 2nd. KeyCorp lifted their target price on Eastman Chemical from $118.00 to $122.00 and gave the company an “overweight” rating in a research note on Monday, April 30th. SunTrust Banks lifted their target price on Eastman Chemical to $105.00 and gave the company a “hold” rating in a research note on Monday, February 5th. They noted that the move was a valuation call. Finally, Citigroup lifted their target price on Eastman Chemical from $103.00 to $108.00 and gave the company a “neutral” rating in a research note on Monday, April 30th. Eight analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $105.40.

Eastman Chemical opened at $104.84 on Wednesday, MarketBeat reports. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.99 and a current ratio of 1.72. Eastman Chemical has a fifty-two week low of $78.59 and a fifty-two week high of $112.45. The stock has a market cap of $15.16 billion, a price-to-earnings ratio of 13.78, a price-to-earnings-growth ratio of 1.32 and a beta of 1.22.

Eastman Chemical (NYSE:EMN) last released its earnings results on Thursday, April 26th. The basic materials company reported $2.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.09 by $0.14. The company had revenue of $2.61 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Eastman Chemical had a return on equity of 22.14% and a net margin of 15.08%. The business’s revenue for the quarter was up 13.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.83 EPS. equities analysts forecast that Eastman Chemical will post 8.58 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 6th. Stockholders of record on Friday, June 15th will be issued a dividend of $0.56 per share. The ex-dividend date of this dividend is Thursday, June 14th. This represents a $2.24 annualized dividend and a dividend yield of 2.14%. Eastman Chemical’s dividend payout ratio is 29.43%.

In other news, CFO Curtis E. Espeland sold 47,000 shares of Eastman Chemical stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $100.00, for a total transaction of $4,700,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Brad A. Lich sold 12,066 shares of Eastman Chemical stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $105.75, for a total value of $1,275,979.50. Following the sale, the executive vice president now owns 18,997 shares of the company’s stock, valued at $2,008,932.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 94,649 shares of company stock valued at $9,656,641. 1.18% of the stock is owned by corporate insiders.

Eastman Chemical Profile

Eastman Chemical Company manufactures and sells materials, specialty additives, chemicals, and fibers in the United States and internationally. The company's Additives & Functional Products segment offers specialty coalescents, specialty and commodity solvents, paint additives, and specialty polymers; hydrocarbon and rosin resins; insoluble sulfur and antidegradant rubber additives; performance resins and amine derivative-based building blocks; heat transfer and aviation fluids; formic acid-based solutions; and metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators.

Top 10 Medical Stocks To Invest In 2019

tags:VIVO,CLNE,HELE,MGIC,JBSS,LH,SONC,APU,PRXL,SRPT,

10 Sales Behaviors That Prospects Hate

3 New Thoughts From the AXA US Individual Annuities Chief

Indexed Life Sales Rise 10%: Wink

John Doak, the Oklahoma insurance commissioner, today gave members of a Senate panel advice that would please many health insurance agents and brokers: He called for the Senate Committee on Health, Education, Labor and Pensions to investigate the Affordable Care Act Navigator program.

"I would ask for the full Senate committee to do an audit of the Navigator program," Doak told Sen. Tammy Baldwin, R-Wis., a Senate HELP Committee member. "Are they doing the job they're supposed to be doing? Where's the checks and balance there?"

Doak was one of five state insurance commissioners who appeared as witnesses at a Senate HELP hearing on stabilizing the individual major medical insurance market. The hearing is one of four the committee has scheduled on the topic for this week and the next. The other witnesses at today's hearing were Mike Kreidler of Washington state; Julie Mix McPeak of Tennessee; Teresa Miller of Pennsylvania; and Lori Wing-Heier of Alaska.

Top 10 Medical Stocks To Invest In 2019: Meridian Bioscience Inc.(VIVO)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Meridian Bioscience (VIVO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Intellia Therapeutics (NASDAQ: NTLA) and Meridian Bioscience (NASDAQ:VIVO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

• [By Logan Wallace]

  VIVO (CURRENCY:VIVO) traded down 0.1% against the dollar during the 24 hour period ending at 0:00 AM Eastern on May 8th. In the last seven days, VIVO has traded down 9.4% against the dollar. One VIVO coin can now be bought for about $0.77 or 0.00008506 BTC on major cryptocurrency exchanges including Cryptopia, CryptoBridge and Stocks.Exchange. VIVO has a market cap of $1.41 million and approximately $9,560.00 worth of VIVO was traded on exchanges in the last day.

Top 10 Medical Stocks To Invest In 2019: Clean Energy Fuels Corp.(CLNE)

Advisors' Opinion:

• [By Paul Ausick]

  Clean Energy Fuels Corp. (NASDAQ: CLNE) dropped about 3.6% Wednesday to post a new 52-week low of $1.62 after closing at $1.68 on Tuesday. The stock’s 52-week high is $3.12. Volume was about 2 million, about 30% above the daily average of around 1.3 million. The company had no specific news.

• [By Jason Hall]

  Natural gas for transportation supplier�Clean Energy Fuels Corp�(NASDAQ:CLNE) reported earnings on May 10, and while the company was profitable on both a GAAP and adjusted basis, growth -- measured in gallons of natural gas delivered -- slowed to almost a trickle, even when adjusted for last year's sale of the biomethane business. At the same time, the cyclical nature of its station construction and expansion business also affected the results, playing a role in a big decline in revenue.�

• [By Lisa Levin] Gainers Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook. ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings. Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings. Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter. Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116. Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings. The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million. Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701. Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings. Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO. Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales. Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
• [By Jason Hall]

  Shares of�Clean Energy Fuels Corp.�(NASDAQ:CLNE) surged as much as 22.7% today, before losing a little steam in afternoon trading. As of 12:20 p.m. EDT, shares were up 13.6% in very heavy trading. At this writing, more than 5 million shares have traded hands, about five times the average volume for the company's stock.�

• [By Paul Ausick]

  Clean Energy Fuels Corp. (NASDAQ: CLNE) saw a drop of about 6.3% in short interest to 4.2 million shares. About 3.1% of the company’s float was short, and days to cover rose from six to nine. The share price fell by 1.8% in the short interest period. The stock closed at $1.91 on Wednesday, up about 2.1% for the day, in a 52-week range of $1.31 to $3.05.

• [By Maxx Chatsko]

  Depending on how investors look at the situation, natural gas transportation fuels leader Clean Energy Fuels (NASDAQ:CLNE) is either oh-so-close to finally cashing in on its long-term potential or on the doorstep of a much worse fate. Considering shares have fallen almost 80% in the last three years, it may seem difficult to remain optimistic. But there are some rays of sunshine piercing through the dark clouds.

Top 10 Medical Stocks To Invest In 2019: Helen of Troy Limited(HELE)

Advisors' Opinion:

• [By Shane Hupp]

  Helen of Troy (NASDAQ:HELE) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday.

• [By Ethan Ryder]

  Deer Consumer Products (OTCMKTS: DEER) and Helen of Troy (NASDAQ:HELE) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Top 10 Medical Stocks To Invest In 2019: Magic Software Enterprises Ltd.(MGIC)

Advisors' Opinion:

• [By Logan Wallace]

  HC Wainwright set a $10.00 target price on Magic Software Enterprises (NASDAQ:MGIC) in a research note released on Thursday morning. The firm currently has a buy rating on the software maker’s stock.

• [By Lisa Levin]

  Magic Software Enterprises Ltd. (NASDAQ: MGIC) is estimated to report quarterly earnings at $0.14 per share on revenue of $67.07 million.

  Canadian Solar Inc. (NASDAQ: CSIQ) is projected to report quarterly earnings at $0.47 per share on revenue of $1.34 billion.

• [By Logan Wallace]

  ValuEngine lowered shares of Magic Software Enterprises (NASDAQ:MGIC) from a buy rating to a hold rating in a report issued on Monday.

  Several other equities research analysts have also recently issued reports on MGIC. Zacks Investment Research raised shares of Magic Software Enterprises from a sell rating to a hold rating in a research report on Wednesday, January 17th. BidaskClub cut shares of Magic Software Enterprises from a sell rating to a strong sell rating in a research report on Tuesday, January 23rd. Finally, HC Wainwright set a $10.00 target price on shares of Magic Software Enterprises and gave the stock a buy rating in a research report on Thursday, March 1st. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of Hold and an average target price of $9.81.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Magic Software Enterprises (MGIC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: John B. Sanfilippo & Son, Inc.(JBSS)

Advisors' Opinion:

• [By Max Byerly]

  The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Top 10 Medical Stocks To Invest In 2019: Laboratory Corporation of America Holdings(LH)

Advisors' Opinion:

• [By Joseph Griffin]

  Envestnet Asset Management Inc. reduced its position in shares of LabCorp (NYSE:LH) by 45.1% during the first quarter, HoldingsChannel.com reports. The fund owned 19,179 shares of the medical research company’s stock after selling 15,727 shares during the quarter. Envestnet Asset Management Inc.’s holdings in LabCorp were worth $3,116,000 at the end of the most recent reporting period.

• [By Max Byerly]

  MUFG Americas Holdings Corp trimmed its stake in LabCorp (NYSE:LH) by 55.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,683 shares of the medical research company’s stock after selling 13,073 shares during the quarter. MUFG Americas Holdings Corp’s holdings in LabCorp were worth $1,728,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Joseph Griffin]

  Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

  Get Laboratory Corp. of America alerts: Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH) (americanbankingnews.com) Credit Suisse Group Lowers Laboratory Corp. of America (LH) to Hold (americanbankingnews.com) Laboratory Corp. of America (LH) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings? (finance.yahoo.com) As Laboratory Corp Of America Holdings (LH) Shares Rose, Shareholder Veritas Investment Management Llp … (djzplanet.com)

  LH has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $204.00 price target (up from $180.00) on shares of Laboratory Corp. of America in a research note on Wednesday, February 7th. Morgan Stanley upped their target price on Laboratory Corp. of America from $182.00 to $192.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. Zacks Investment Research downgraded Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Mizuho set a $178.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, Robert W. Baird set a $183.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Thursday, February 8th. Seven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $189.19.

Top 10 Medical Stocks To Invest In 2019: Sonic Corp.(SONC)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Sonic Drive-In (SONC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Sonic Drive-In (NASDAQ:SONC) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

• [By Peter Graham]

  Small cap burger stock Sonic Corporation (NASDAQ: SONC) reported fiscal Q1 2018 earnings after the market closed Thursday that exceeded Wall Street expectations. Total revenues were $105.428 million versus $129.551 million as�system same-store sales declined 1.7% - consisting of a 1.6% same-store sales decrease at franchise drive-ins and a 3.2% decrease at company drive-in. Net income totaled $11.4 million versus net income of $13.1 million. The CEO commented:

Top 10 Medical Stocks To Invest In 2019: AmeriGas Partners, L.P.(APU)

Advisors' Opinion:

• [By John Bromels]

  If you're like me, you probably use branded propane tanks from�AmeriGas Partners�(NYSE:APU) or�Blue Rhino, which is owned by�Ferrellgas Partners, L.P.�(NYSE:FGP)�(Full disclosure: Propane is propane. I use AmeriGas because it's what the local convenience store sells.) Either one will get your burgers cooked, but which one will keep your portfolio cooking along?�

Top 10 Medical Stocks To Invest In 2019: PAREXEL International Corporation(PRXL)

Advisors' Opinion:

• [By Logan Wallace]

  News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Medical Stocks To Invest In 2019: Sarepta Therapeutics, Inc.(SRPT)

Advisors' Opinion:

• [By Shane Hupp]

  Sarepta Therapeutics (NASDAQ:SRPT)’s share price reached a new 52-week high and low on Wednesday after Leerink Swann raised their price target on the stock from $88.00 to $121.00. Leerink Swann currently has an outperform rating on the stock. Sarepta Therapeutics traded as low as $95.67 and last traded at $94.81, with a volume of 42782 shares trading hands. The stock had previously closed at $92.22.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Sarepta Therapeutics (SRPT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Sarepta Therapeutics (NASDAQ:SRPT) had its target price increased by Morgan Stanley from $87.00 to $91.00 in a report issued on Friday. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock.